IMC Chicago’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.35M Buy
363,300
+134,900
+59% +$2.2M ﹤0.01% 1725
2025
Q4
$2.94M Buy
228,400
+43,900
+24% +$465K ﹤0.01% 2122
2025
Q3
$1.56M Buy
184,500
+25,500
+16% +$240K ﹤0.01% 2414
2025
Q2
$1.37M Buy
159,000
+33,300
+26% +$247K ﹤0.01% 2265
2025
Q1
$1.08M Buy
125,700
+24,300
+24% +$173K ﹤0.01% 2224
2024
Q4
$678K Buy
101,400
+30,400
+43% +$226K ﹤0.01% 2587
2024
Q3
$510K Sell
71,000
-29,600
-29% -$273K ﹤0.01% 2410
2024
Q2
$1.05M Buy
100,600
+58,800
+141% +$587K ﹤0.01% 1942
2024
Q1
$420K Sell
41,800
-25,900
-38% -$278K ﹤0.01% 2128
2023
Q4
$1.03M Buy
67,700
+24,800
+58% +$343K ﹤0.01% 1422
2023
Q3
$600K Buy
42,900
+18,000
+72% +$272K ﹤0.01% 1378
2023
Q2
$330K Sell
24,900
-3,900
-14% -$53.1K ﹤0.01% 1238
2023
Q1
$464K Buy
28,800
+12,300
+75% +$218K ﹤0.01% 1179
2022
Q4
$246K Sell
16,500
-700
-4% -$12.2K ﹤0.01% 1219
2022
Q3
$342K Buy
+17,200
New +$426K ﹤0.01% 1134
2021
Q1
Sell
-10,300
Closed -$495K 1103
2020
Q4
$495K Sell
10,300
-300
-3% -$14.5K ﹤0.01% 956
2020
Q3
$494K Sell
10,600
-1,500
-12% -$73.6K ﹤0.01% 857
2020
Q2
$544K Sell
12,100
-3,500
-22% -$136K ﹤0.01% 795
2020
Q1
$455K Buy
+15,600
New +$581K ﹤0.01% 743

Other funds holding HLF

IMC Chicago's HLF Position: Q1 2026 in Review

IMC Chicago sold out of Herbalife (HLF) in Q1 2026, closing a stake of 75,268 shares — an estimated $1.23M sold.

IMC Chicago first reported a position in HLF in Q3 2023 and held it in 8 quarters. The position peaked at $1.62M in Q2 2025. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • IMC Chicago reported no remaining Herbalife position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 75,268 Herbalife shares in Q1 2026, an estimated $1.23M.
  • IMC Chicago first reported a position in Herbalife in Q3 2023 and held it in 8 quarters.
  • IMC Chicago's Herbalife position peaked at $1.62M in Q2 2025.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.